2024 Q2 Form 10-K Financial Statement

#000149315224037185 Filed on September 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 2023
Revenue $236.9M $8.400M $1.159B
YoY Change -4.13% -99.28%
Cost Of Revenue $210.0M $1.000M $1.055B
YoY Change -3.17% -99.91%
Gross Profit $26.92M $7.400M $103.9M
YoY Change -10.98% -92.88%
Gross Profit Margin 11.36% 88.1% 8.97%
Selling, General & Admin $24.86M $57.65M $59.06M
YoY Change -8.56% -2.38% 1.63%
% of Gross Profit 92.35% 779.07% 56.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.425M $1.900M $2.200M
YoY Change -20.12% -13.64% -29.03%
% of Gross Profit 5.29% 25.68% 2.12%
Operating Expenses $26.29M $114.7M $136.7M
YoY Change -9.27% -16.05% 5136.78%
Operating Profit $635.0K $14.14M -$32.75M
YoY Change -50.04% -143.18% 1155.58%
Interest Expense -$2.727M $11.20M $11.72M
YoY Change 4.48% -4.4% 101.29%
% of Operating Profit -429.45% 79.2%
Other Income/Expense, Net -$41.00K -$12.29M -$11.72M
YoY Change 4000.0% 4.88% -301.44%
Pretax Income -$2.271M $1.853M -$44.46M
YoY Change -1.6% -104.17% -1485.96%
Income Tax -$4.777M -$2.728M -$9.058M
% Of Pretax Income -147.22%
Net Earnings $2.506M $4.581M -$35.40M
YoY Change -154.13% -112.94% -1302.77%
Net Earnings / Revenue 1.06% 54.54% -3.06%
Basic Earnings Per Share $0.09 -$0.74
Diluted Earnings Per Share $0.05 $0.09 -$0.74
COMMON SHARES
Basic Shares Outstanding 50.93M 50.83M shares 48.14M
Diluted Shares Outstanding 50.84M shares 48.14M

Balance Sheet

Concept 2024 Q2 2024 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.129M $1.129M $865.0K
YoY Change 30.52% 30.52%
Cash & Equivalents $1.129M $1.129M $865.0K
Short-Term Investments
Other Short-Term Assets $5.298M $5.298M $8.299M
YoY Change -36.16% -36.16%
Inventory $97.43M $97.43M $146.8M
Prepaid Expenses
Receivables $92.36M $92.36M $104.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $196.2M $196.2M $260.9M
YoY Change -24.78% -24.78%
LONG-TERM ASSETS
Property, Plant & Equipment $12.94M $35.07M $18.28M
YoY Change -3.57% 91.87%
Goodwill $89.12M
YoY Change 0.0%
Intangibles $13.38M
YoY Change -22.9%
Long-Term Investments
YoY Change
Other Assets $503.0K $7.036M $3.916M
YoY Change -50.54% 79.67%
Total Long-Term Assets $144.6M $144.6M $128.7M
YoY Change 12.38% 12.38% 9.22%
TOTAL ASSETS
Total Short-Term Assets $196.2M $196.2M $260.9M
Total Long-Term Assets $144.6M $144.6M $128.7M
Total Assets $340.8M $340.8M $389.5M
YoY Change -12.51% -12.51% 230.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $133.2M $133.2M $151.6M
YoY Change -12.14% -12.14%
Accrued Expenses $9.371M $11.35M $13.24M
YoY Change 0.33% -14.29% 727.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $133.8M
YoY Change -100.0% -100.0% 26655.2%
Long-Term Debt Due $2.838M $2.838M $2.449M
YoY Change 15.88% 15.88%
Total Short-Term Liabilities $147.9M $147.9M $301.2M
YoY Change -50.9% -50.9% 12451.63%
LONG-TERM LIABILITIES
Long-Term Debt $84.60M $84.60M $7.029M
YoY Change 1103.63% 1103.63%
Other Long-Term Liabilities $20.66M $20.66M $1.728M
YoY Change 1095.6% 1095.6% 146.86%
Total Long-Term Liabilities $105.3M $105.3M $8.757M
YoY Change 1102.04% 1102.04% 1151.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $147.9M $147.9M $301.2M
Total Long-Term Liabilities $105.3M $105.3M $8.757M
Total Liabilities $253.2M $253.2M $310.0M
YoY Change -18.33% -18.33% 9899.87%
SHAREHOLDERS EQUITY
Retained Earnings $39.65M
YoY Change 13.06%
Common Stock $5.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $87.63M $87.63M $79.53M
YoY Change
Total Liabilities & Shareholders Equity $340.8M $340.8M $389.5M
YoY Change -12.51% -12.51% 230.67%

Cashflow Statement

Concept 2024 Q2 2024 2023
OPERATING ACTIVITIES
Net Income $2.506M $4.581M -$35.40M
YoY Change -154.13% -112.94% -1302.77%
Depreciation, Depletion And Amortization $1.425M $1.900M $2.200M
YoY Change -20.12% -13.64% -29.03%
Cash From Operating Activities $8.272M $55.77M $3.388M
YoY Change -267.93% 1546.19% -380.32%
INVESTING ACTIVITIES
Capital Expenditures -$3.000K $183.0K $825.0K
YoY Change -100.36% -77.82% 1550.0%
Acquisitions -$1.000K
YoY Change
Other Investing Activities $23.00K $66.00K $1.000K
YoY Change 2200.0% 6500.0%
Cash From Investing Activities $26.00K -$117.0K -$824.0K
YoY Change -103.15% -85.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.130M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.809M -$55.39M -3.157M
YoY Change -257.5% 1654.51% -728.66%
NET CHANGE
Cash From Operating Activities 8.272M $55.77M 3.388M
Cash From Investing Activities 26.00K -$117.0K -824.0K
Cash From Financing Activities -8.809M -$55.39M -3.157M
Net Change In Cash -511.0K $266.0K -593.0K
YoY Change 223.42% -144.86% -16.06%
FREE CASH FLOW
Cash From Operating Activities $8.272M $55.77M $3.388M
Capital Expenditures -$3.000K $183.0K $825.0K
Free Cash Flow $8.275M $55.59M $2.563M
YoY Change -243.89% 2068.94% -303.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001823584
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2024Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
usd
CY2023Q2 us-gaap Subordinated Long Term Debt
SubordinatedLongTermDebt
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024 AENT Interest Charge Domestic International Sales Corporation Commissions
InterestChargeDomesticInternationalSalesCorporationCommissions
usd
CY2023 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
usd
CY2024 us-gaap Inventory Write Down
InventoryWriteDown
usd
CY2024 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
usd
CY2024 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
CY2024 AENT Conversion Of Treasury Stock
ConversionOfTreasuryStock
usd
CY2024 AENT Non Cash Investing Activity Of Capital Contribution
NonCashInvestingActivityOfCapitalContribution
usd
CY2024 AENT Business Combination Reverse Recapitalization
BusinessCombinationReverseRecapitalization
usd
CY2023Q2 AENT Prepaid Acquisitions Other Assets Current
PrepaidAcquisitionsOtherAssetsCurrent
usd
CY2023Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
usd
CY2024Q2 AENT Prepaid Manufacturing Components Other Assets Current
PrepaidManufacturingComponentsOtherAssetsCurrent
usd
CY2024Q2 us-gaap Prepaid Rent
PrepaidRent
usd
CY2023Q2 AENT Prepaid Inventory Other Assets Current
PrepaidInventoryOtherAssetsCurrent
usd
CY2024 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Fdii Amount
EffectiveIncomeTaxRateReconciliationFdiiAmount
usd
CY2023 AENT Income Tax Reconciliation Change In Deferred Tax True Up
IncomeTaxReconciliationChangeInDeferredTaxTrueUp
usd
CY2023 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
usd
CY2024 AENT Effective Income Tax Rate Reconciliation Capitalized Acquisition Costs Percent
EffectiveIncomeTaxRateReconciliationCapitalizedAcquisitionCostsPercent
pure
CY2024 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2023Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
usd
CY2024Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
usd
CY2023Q1 AENT Related Party Transaction Term Of Advance Notice Period To Terminate Agreement
RelatedPartyTransactionTermOfAdvanceNoticePeriodToTerminateAgreement
P6M
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2024 AENT Class Of Warrants Share Exercised
ClassOfWarrantsShareExercised
shares
CY2024 AENT Class Of Warrants Value Exercised
ClassOfWarrantsValueExercised
usd
CY2024 AENT Fair Value Adjustment Of Warrants Shares
FairValueAdjustmentOfWarrantsShares
shares
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
8201 Peters Road
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1000
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Plantation
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33324
CY2024 dei City Area Code
CityAreaCode
(954)
CY2024 dei Local Phone Number
LocalPhoneNumber
255-4000
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
117070000 usd
CY2024 AENT No Insider Trading Flag
NoInsiderTradingFlag
true
CY2024 dei Auditor Firm
AuditorFirmId
243
CY2024 dei Auditor Name
AuditorName
BDO USA, P.C
CY2024 dei Auditor Location
AuditorLocation
Miami, Florida
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1129000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
865000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92357000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104939000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
97429000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
146763000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5298000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
8299000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
196213000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
260866000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12942000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13421000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22124000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4855000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
89116000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
89116000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13381000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17356000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
503000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1017000 usd
CY2024Q2 AENT Deferred Tax Asset Net
DeferredTaxAssetNet
6533000 usd
CY2023Q2 AENT Deferred Tax Asset Net
DeferredTaxAssetNet
2899000 usd
CY2024Q2 us-gaap Assets
Assets
340812000 usd
CY2023Q2 us-gaap Assets
Assets
389530000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
133221000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
151622000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9371000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9340000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1979000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3902000 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2838000 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2449000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
495000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
511000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
150000 usd
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
133281000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
147920000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
301239000 usd
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
69587000 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5016000 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
7029000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20413000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1522000 usd
CY2024Q2 us-gaap Subordinated Long Term Debt
SubordinatedLongTermDebt
10000000 usd
CY2024Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
247000 usd
CY2023Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
206000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
253183000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
309996000 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50957370 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50957370 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49167170 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49167170 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48058000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
44542000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-79000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-77000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39645000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
35064000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
87629000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
79534000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
340812000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
389530000 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1100483000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1158722000 usd
CY2024 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
971594000 usd
CY2023 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1054788000 usd
CY2024 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
48818000 usd
CY2023 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
62841000 usd
CY2024 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57651000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59060000 usd
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5880000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6629000 usd
CY2024 AENT Transaction Costs
TransactionCosts
2086000 usd
CY2023 AENT Transaction Costs
TransactionCosts
5014000 usd
CY2023 AENT Interest Charge Domestic International Sales Corporation Commissions
InterestChargeDomesticInternationalSalesCorporationCommissions
2833000 usd
CY2024 us-gaap Restructuring Charges
RestructuringCharges
280000 usd
CY2023 us-gaap Restructuring Charges
RestructuringCharges
306000 usd
CY2024 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-33000 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3000 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
114748000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
136680000 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
14141000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-32746000 usd
CY2024 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
12247000 usd
CY2023 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
11715000 usd
CY2024 AENT Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
41000 usd
CY2023 AENT Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
1000 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12288000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11716000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1853000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44462000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2728000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9058000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
4581000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-35404000 usd
CY2024 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-11000 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4579000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35415000 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50828548 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48138393 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50837148 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48138393 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
108928000 usd
CY2023 AENT Adjustments To Additional Paid In Capital Capital Contribution
AdjustmentsToAdditionalPaidInCapitalCapitalContribution
6592000 usd
CY2023 AENT Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
-787000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-11000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
216000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-35404000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
79534000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
79534000 usd
CY2024 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1900000 usd
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2130000 usd
CY2024 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000 usd
CY2024 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1386000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
4581000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
4581000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
87629000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
87629000 usd
CY2024 us-gaap Profit Loss
ProfitLoss
4581000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-35404000 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
10800000 usd
CY2024 us-gaap Depreciation
Depreciation
1904000 usd
CY2023 us-gaap Depreciation
Depreciation
2221000 usd
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3976000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4408000 usd
CY2024 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
861000 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
167000 usd
CY2024 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
687000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
598000 usd
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3634000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8171000 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
1386000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
216000 usd
CY2024 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-33000 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3000 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11896000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4626000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-245000 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-49334000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-99729000 usd
CY2024 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
517000 usd
CY2023 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-1533000 usd
CY2024 AENT Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
17269000 usd
CY2023 AENT Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-3505000 usd
CY2024 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
16968000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3893000 usd
CY2024 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3357000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5031000 usd
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-18401000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-68950000 usd
CY2024 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-423000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-952000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
55773000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3388000 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-1000 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
183000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
825000 usd
CY2024 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
66000 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-117000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-824000 usd
CY2024 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2965000 usd
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
304000 usd
CY2024 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1095772000 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1092306000 usd
CY2024 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1035428000 usd
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1089453000 usd
CY2024 us-gaap Repayments Of Subordinated Short Term Debt
RepaymentsOfSubordinatedShortTermDebt
36000000 usd
CY2023 us-gaap Repayments Of Subordinated Short Term Debt
RepaymentsOfSubordinatedShortTermDebt
7596000 usd
CY2024 us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
46000000 usd
CY2023 us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
7596000 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2130000 usd
CY2024 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4211000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-55390000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3157000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
266000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-593000 usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-11000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
865000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1469000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1129000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
865000 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
12247000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
11425000 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
444000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
648000 usd
CY2023 AENT Conversion Of Treasury Stock
ConversionOfTreasuryStock
2674000 usd
CY2024 AENT Non Cash Investing Activity Of Fixed Asset With Finance Debt
NonCashInvestingActivityOfFixedAssetWithFinanceDebt
7853000 usd
CY2023 AENT Non Cash Investing Activity Of Fixed Asset With Finance Debt
NonCashInvestingActivityOfFixedAssetWithFinanceDebt
10080000 usd
CY2023 AENT Non Cash Investing Activity Of Capital Contribution
NonCashInvestingActivityOfCapitalContribution
6592000 usd
CY2023 AENT Business Combination Reverse Recapitalization
BusinessCombinationReverseRecapitalization
-787000 usd
CY2024 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zLObueqeFn01" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zTL9mLYJPjx1">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates inherent in the preparation of the accompanying consolidated financial statements include management’s estimates of sales returns, warrants fair value, rebates, goodwill impairment, and inventory valuation. On an ongoing basis, management evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024 us-gaap Net Income Loss
NetIncomeLoss
4581000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-35404000 usd
CY2024 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
60000000 shares
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9920090 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9920090 shares
CY2024 us-gaap Advertising Expense
AdvertisingExpense
7300000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
7900000 usd
CY2024 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-11000 usd
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zEhED6uml8X4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zJidln7gnsja">Concentrations</span></span></p> <p id="xdx_891_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQijUaHCoeee" style="font: 12pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span id="xdx_8B4_zze1WSsFYyyg" style="display: none">Schedule of Concentration of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customers:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Year Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Year Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold">Revenues</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 64%">Customer #1</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPis79Fn3yfd" title="Concentration of credit risk">17.8</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20230630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zwf1VzPnzh2i" title="Concentration of credit risk">23.1</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer #2</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zcxkJo34NUc7" title="Concentration of credit risk">11.0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_fKg_____zWnAJTZcRnO7" title="Concentration of credit risk"><span style="-sec-ix-hidden: xdx2ixbrl0720">-</span></span></span>*</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer #3</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zcbzqA24YExk" title="Concentration of credit risk">10.2</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_fKg_____zZdlmIxsvdWh" title="Concentration of credit risk"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></span></span>*</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F08_zioPqT7o85We" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"> <span id="xdx_F1B_z2D6MECbHaYj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 10%</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold">Receivables</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 64%">Customer #1</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zcn8nlGWzt8j" title="Concentration of credit risk">20.2</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20230630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zQOksarATTRb" title="Concentration of credit risk">15.5</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer #2</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0bbplVdlq82" title="Concentration of credit risk">12.3</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20230630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_ztD0iOmGwNUa" title="Concentration of credit risk">12.1</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer #3</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4oZUwA0gtTl" title="Concentration of credit risk"><span style="-sec-ix-hidden: xdx2ixbrl0735">-</span></span></span>*</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20230630__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zm1HfY8473d9" title="Concentration of credit risk">10.5</span></td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F07_zQBirEGSlP15" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F15_zSSFweozvp7j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 10%</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suppliers:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Year Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Year Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold">Purchases</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 64%">Supplier #1</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PaymentsToContractWithSupplierMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierOneMember_zW7HBBwyjT04" title="Concentration of credit risk">21.1</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PaymentsToContractWithSupplierMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierOneMember_zYjyAlPUEIv3" title="Concentration of credit risk">14.6</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Supplier #2</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PaymentsToContractWithSupplierMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierTwoMember_zQzflb56j9q5" title="Concentration of credit risk">18.4</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PaymentsToContractWithSupplierMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierTwoMember_zJjJ71OOjls3" title="Concentration of credit risk">12.9</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier #3</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PaymentsToContractWithSupplierMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierThreeMember_zrbRda8TvvM3" title="Concentration of credit risk">10.4</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PaymentsToContractWithSupplierMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierThreeMember_zesZJMgwICif" title="Concentration of credit risk"><span style="-sec-ix-hidden: xdx2ixbrl0750">-</span></span> </span>*</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F03_zD9nt58fbwCi" style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F10_zgG7y1TKVE7g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 10%</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold">Payables</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 64%">Supplier #1</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierOneMember_zTVMprNiZDaf" title="Concentration of credit risk">15.8</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierOneMember_zUCVIGYz2HGe" title="Concentration of credit risk">12.3</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Supplier #2</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierTwoMember_z6DzyspkNWF2" title="Concentration of credit risk">12.3</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier #3</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SupplierThreeMember_zKM5GTHgHRQb" title="Concentration of credit risk">10.6</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F01_z03xQgq28xrj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F1A_z8icRvUO42oi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 10%</span></td> </tr></table> <p id="xdx_8AD_zwkZg3dgkssb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
93827000 usd
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
106467000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1470000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1528000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92357000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104939000 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
10800000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
105749000 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
156016000 usd
CY2024Q2 us-gaap Inventory Adjustments
InventoryAdjustments
8320000 usd
CY2023Q2 us-gaap Inventory Adjustments
InventoryAdjustments
9253000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
97429000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
146763000 usd
CY2024Q2 AENT Prepaid Intellectual Property Other Assets Current
PrepaidIntellectualPropertyOtherAssetsCurrent
2628000 usd
CY2023Q2 AENT Prepaid Intellectual Property Other Assets Current
PrepaidIntellectualPropertyOtherAssetsCurrent
2890000 usd
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
183000 usd
CY2023Q2 us-gaap Prepaid Insurance
PrepaidInsurance
1365000 usd
CY2024Q2 AENT Prepaid Acquisitions Other Assets Current
PrepaidAcquisitionsOtherAssetsCurrent
55000 usd
CY2024Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
310000 usd
CY2023Q2 AENT Prepaid Manufacturing Components Other Assets Current
PrepaidManufacturingComponentsOtherAssetsCurrent
164000 usd
CY2023Q2 us-gaap Prepaid Rent
PrepaidRent
1054000 usd
CY2024Q2 AENT Prepaid Maintenance Other Assets Current
PrepaidMaintenanceOtherAssetsCurrent
795000 usd
CY2023Q2 AENT Prepaid Maintenance Other Assets Current
PrepaidMaintenanceOtherAssetsCurrent
1572000 usd
CY2024Q2 AENT Prepaid Inventory Other Assets Current
PrepaidInventoryOtherAssetsCurrent
559000 usd
CY2024Q2 us-gaap Supplies
Supplies
768000 usd
CY2023Q2 us-gaap Supplies
Supplies
1254000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5298000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
8299000 usd
CY2024Q2 us-gaap Deposits Assets
DepositsAssets
273000 usd
CY2023Q2 us-gaap Deposits Assets
DepositsAssets
270000 usd
CY2024Q2 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
230000 usd
CY2023Q2 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
747000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
503000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1017000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57737000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57742000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44795000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44321000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12942000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13421000 usd
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1900000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2200000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
89116000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
79703000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
89116000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
79703000 usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
9213000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
89116000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
89116000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
89116000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
89116000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
103983000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-90602000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13381000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-86627000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17356000 usd
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4000000.0 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4400000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3326000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3015000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2966000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1938000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
659000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1477000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13381000 usd
CY2024Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
5012000 usd
CY2023Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
5203000 usd
CY2024Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2782000 usd
CY2023Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2765000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1577000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1372000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9371000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9340000 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
133000000 usd
CY2024Q2 us-gaap Debt Current
DebtCurrent
73000000 usd
CY2024 us-gaap Interest Expense
InterestExpense
11200000 usd
CY2023 us-gaap Interest Expense
InterestExpense
11400000 usd
CY2024 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
900000 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
200000 usd
CY2024 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
100000 usd
CY2023 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
100000 usd
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
218000 usd
CY2023Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
218000 usd
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
475000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-27000 usd
CY2024 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
431000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-860000 usd
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
906000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-887000 usd
CY2024 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2856000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5584000 usd
CY2024 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-778000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2587000 usd
CY2024 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-3634000 usd
CY2023 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-8171000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2728000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9058000 usd
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
389000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-9337000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-347000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.19 pure
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-3446000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.08 pure
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
20000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
0.01 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
0 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Fdii Amount
EffectiveIncomeTaxRateReconciliationFdiiAmount
293000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Fdii Percent
EffectiveIncomeTaxRateReconciliationFdiiPercent
0.16 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Fdii Percent
EffectiveIncomeTaxRateReconciliationFdiiPercent
-0 pure
CY2024 AENT Income Tax Reconciliation Change In Deferred Tax True Up
IncomeTaxReconciliationChangeInDeferredTaxTrueUp
-2730000 usd
CY2024 AENT Effective Income Tax Rate Reconciliation Change In Deferred Tax True Up
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxTrueUp
-1.47 pure
CY2023 AENT Effective Income Tax Rate Reconciliation Change In Deferred Tax True Up
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxTrueUp
0 pure
CY2024 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-233000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-0.13 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-0 pure
CY2023 AENT Income Tax Out Of Period Adjustment
IncomeTaxOutOfPeriodAdjustment
2914000 usd
CY2023 AENT Effective Income Tax Rate Reconciliation Capitalized Acquisition Costs Percent
EffectiveIncomeTaxRateReconciliationCapitalizedAcquisitionCostsPercent
0.07 pure
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
811000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01 pure
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2728000 usd
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.47 pure
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9058000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.21 pure
CY2024Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
590000 usd
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
590000 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8607000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12076000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
149000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
42000 usd
CY2024Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
2990000 usd
CY2024Q2 AENT Deferred Tax Assets Section248 Organization Costs
DeferredTaxAssetsSection248OrganizationCosts
1827000 usd
CY2023Q2 AENT Deferred Tax Assets Section248 Organization Costs
DeferredTaxAssetsSection248OrganizationCosts
1285000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
3481000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1343000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
5800000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
1390000 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23444000 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16726000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
946000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
918000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
1426000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3864000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3871000 usd
CY2024Q2 AENT Deferred Tax Liabilities Operating Lease Assets
DeferredTaxLiabilitiesOperatingLeaseAssets
5732000 usd
CY2023Q2 AENT Deferred Tax Liabilities Operating Lease Assets
DeferredTaxLiabilitiesOperatingLeaseAssets
1244000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
6397000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
6340000 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
16911000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
13827000 usd
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
6533000 usd
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2899000 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
31600000 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
22900000 usd
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
22900000 usd
CY2024 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
0 usd
CY2023 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
0 usd
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
511000 usd
CY2023Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
150000 usd
CY2024Q2 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
20913200 usd
CY2024Q2 AENT Loss Contingency Damages Paid Percentage
LossContingencyDamagesPaidPercentage
0.09 pure
CY2024 us-gaap Revenues
Revenues
8400000 usd
CY2023 us-gaap Revenues
Revenues
16800000 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
1000000.0 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
8300000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21900000 usd
CY2024 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
183000 usd
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
204000 usd
CY2024 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4000 usd
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
12000 usd
CY2024 us-gaap Operating Lease Cost
OperatingLeaseCost
3779000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
3852000 usd
CY2024 us-gaap Short Term Lease Cost
ShortTermLeaseCost
73000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
46000 usd
CY2024 us-gaap Variable Lease Cost
VariableLeaseCost
2273000 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
954000 usd
CY2024 us-gaap Lease Cost
LeaseCost
6312000 usd
CY2023 us-gaap Lease Cost
LeaseCost
5068000 usd
CY2024 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
5000 usd
CY2023 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
12000 usd
CY2024 us-gaap Operating Lease Payments
OperatingLeasePayments
4080000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
4193000 usd
CY2024 AENT Financing Cash Flows From Finance Leases
FinancingCashFlowsFromFinanceLeases
196000 usd
CY2023 AENT Financing Cash Flows From Finance Leases
FinancingCashFlowsFromFinanceLeases
208000 usd
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
7853000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
10080000 usd
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
21900000 usd
CY2024 AENT Right Of Use Remeasurement
RightOfUseRemeasurement
-9000 usd
CY2023 AENT Right Of Use Remeasurement
RightOfUseRemeasurement
-9000 usd
CY2024Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y3M10D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y1M17D
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y6M
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y5M23D
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0333 pure
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0368 pure
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0568 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0414 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3099000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
3338000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4115000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
3340000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4121000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1988000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4218000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4352000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
7173000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
27078000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
8666000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4686000 usd
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
812000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
22392000 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
7854000 usd
CY2024 AENT Common Stock Conversion Ratio From One Class To Another Description
CommonStockConversionRatioFromOneClassToAnotherDescription
converted to Class A shares on a 1:1 basis
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
600000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
463800 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
459200 shares
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
449000 shares
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
10200 shares
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
1400000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
200000 usd
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2024Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
247000 usd
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
206000 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4170090 shares
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
206000 usd
CY2024 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
41000 usd
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4170090 shares
CY2024Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
247000 usd

Files In Submission

Name View Source Status
0001493152-24-037185-index-headers.html Edgar Link pending
0001493152-24-037185-index.html Edgar Link pending
0001493152-24-037185.txt Edgar Link pending
0001493152-24-037185-xbrl.zip Edgar Link pending
aent-20240630.xsd Edgar Link pending
ex19.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
aent-20240630_cal.xml Edgar Link unprocessable
aent-20240630_def.xml Edgar Link unprocessable
aent-20240630_lab.xml Edgar Link unprocessable
aent-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending